Vagus Nerve Stimulation : Changing the Paradigm for Chronic Severe Depression? - 10/08/18
Riassunto |
Vagus nerve stimulation (VNS) has been studied for its effect on treatment-resistant depression. Open-label studies have shown a significant positive effect in an especially treatment-resistant depressive population. Insurance company support for VNS has been limited but may be reviewed given recent positive open-label data. Coming developments in novel external ways to stimulate the vagus nerve may revive interest in this area. This article reviews the clinical development of VNS starting with the first recognition of its potential for treating depression, parses the results of several large clinical trials, and suggests a future path for optimal clinical development and use.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Major depression, Treatment-resistant major depression, Vagus nerve stimulation, Neurostimulation
Mappa
Disclosure Statement: Dr C.R. Conway is a research design consultant to LivaNova, the makers of the vagus nerve stimulation device. Dr S.T. Aaronson is a consultant to Neuronetics, LivaNova, Alkermes, and Genomind. He serves on the speaker boards for Sunovion, Neurocrine, and Otsuka and has received research support from Neuronetics. |
Vol 41 - N° 3
P. 409-418 - Settembre 2018 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?